← back to search

Matthias Müller

TU Dortmund University · DE
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Bacterial Genetics and Biotechnology, RNA and protein synthesis mechanisms, Protein Kinase Regulation and GTPase Signaling, and Cellular transport and secretion.
h-index
46
citations
6,374
works
143
NIH funding
primary concept
email

Recent publications

Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GIST
Journal of Medicinal Chemistry 2025cited by 2position: middledoi
Lethal Borna disease virus 1 infections of humans and animals – in-depth molecular epidemiology and phylogeography
Nature Communications 2024cited by 27position: middledoi
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA
Nature Communications 2024cited by 24position: middledoi
Lethal Borna disease virus 1 (BoDV-1) infections of humans and animals – in-depth molecular epidemiology and phylogeography
Research Square 2023cited by 1position: middledoi
Kohlenhydrate, Lipide, Aminosäuren und Nucleotide – Bausteine des Lebens
2022cited by 0position: lastdoi
Cellular model system to dissect the isoform-selectivity of Akt inhibitors
Nature Communications 2021cited by 53position: middledoi
Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach
Journal of Medicinal Chemistry 2020cited by 18position: middledoi
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal Cancer
Cancer Research 2019cited by 90position: middledoi
Mobility-Based Quantification of Multivalent Virus-Receptor Interactions: New Insights Into Influenza A Virus Binding Mode
Nano Letters 2019cited by 73position: firstdoi
Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity
Angewandte Chemie International Edition 2019cited by 70position: middledoi
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S
Chemical Science 2019cited by 51position: middledoi
Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity
Angewandte Chemie 2019cited by 9position: middledoi
Simultaneous impairment of mitochondrial fission and fusion reduces mitophagy and shortens replicative lifespan
Scientific Reports 2015cited by 120position: middledoi
Mechanismen der Glucosehomöostase
Springer-Lehrbuch 2014cited by 0position: lastdoi
Kohlenhydrate, Lipide, Aminosäuren und Nucleotide – Bausteine des Lebens
Springer-Lehrbuch 2014cited by 0position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel Rauh · Novartis (Switzerland)6 papers (2019–2025) · 5 papers (2019–2024)Georg Löffler · University of Regensburg3 papers (2014–2022) · 3 papers (2019–2021)Sebastian Bauer · TU Dortmund University3 papers (2020–2025) · 3 papers (2019–2021)Kristina Althoff · German Cancer Research Center3 papers (2019–2021)Franziska Glanemann · German Cancer Research Center3 papers (2019–2021) · 3 papers (2019–2021) · 3 papers (2019–2021)Jens T. Siveke · Heinrich Heine University Düsseldorf3 papers (2019–2021) · 2 papers (2024–2025) · 2 papers (2020–2024) · 2 papers (2024–2025) · 2 papers (2024–2025) · 2 papers (2020–2021) · 2 papers (2020–2025) · 2 papers (2024–2025) · 2 papers (2020–2025) · 2 papers (2020–2024)